Brief: Apogee Therapeutics Provides Pipeline Progress
Nov 10 (Reuters) - Apogee Therapeutics Inc APGE.O: APOGEE THERAPEUTICS PROVIDES PIPELINE PROGRESS AND REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS Source text: ID:nGNXb1cRTc Further company coverage: APGE.O ((reuters.briefs@thomsonreuters.com;))
Recent news on Apogee Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Abbvie Seeks At Least $8 Billion In Debt To Fund Apogee Deal - Bloomberg News
Street View: Strength in AbbVie's immunology pipeline to support revenue growth
AbbVie trims 2026 profit view on Apogee deal, tops second-quarter estimates (updated)